Oncolines – Case Studies
Oncolines B.V. was founded in 2021 as a spin-off company of Netherlands Translational Research Center B.V. (NTRC), a biotech company established in Oss (The Netherlands) in 2011 by former employees of Organon/MSD.
Oncolines is a precision medicine services company in oncology and cancer immunotherapy. By cancer cell panel profiling, we identify predictive drug response biomarkers, new disease indications and synergistic drug combinations. To investigate the mechanism of action of compounds, we perform gene and protein expression analysis, DNA and RNA sequencing. With our extensive reference compound database we identify differentiation and mechanism of action. We help cancer researchers to move their projects to the clinic faster.